Focus on gastrointestinal and liver cancers.

Digestive cancers, such as colorectal cancer, gastric cancer and liver cancer, remain major threats to human health in coming decades and their epidemiology is under dynamic changes. Recent advances in genotyping and sequencing technologies together with other molecular and cellular biology techniques have led to a clearer delineation of the pathogenic mechanisms underlying genetic and environmental factors that contribute to digestive cancers. Such expansion of knowledge continues to fuel the development of novel biomarkers and therapeutics. In this special issue of Seminars in Cancer Biology, hot topics in basic and translational research of digestive cancers will be reviewed.

[1]  M. Meyerson,et al.  Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. , 2013, Cell host & microbe.

[2]  M. Todaro,et al.  Tumor and its microenvironment: a synergistic interplay. , 2013, Seminars in cancer biology.

[3]  A. Jemal,et al.  Global Patterns of Cancer Incidence and Mortality Rates and Trends , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[4]  Jun Yu,et al.  Obesity, insulin resistance, NASH and hepatocellular carcinoma. , 2013, Seminars in cancer biology.

[5]  Jun Yu,et al.  MicroRNA in colorectal cancer: from benchtop to bedside. , 2011, Carcinogenesis.

[6]  A. Cheng,et al.  Epigenetic regulation of hepatocellular carcinoma in non-alcoholic fatty liver disease. , 2013, Seminars in cancer biology.

[7]  D. Graham,et al.  Eradication of gastric cancer is now both possible and practical. , 2013, Seminars in cancer biology.

[8]  C. Cho,et al.  β-Adrenergic system, a backstage manipulator regulating tumour progression and drug target in cancer therapy. , 2013, Seminars in cancer biology.

[9]  H. El‐Serag,et al.  Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[10]  Y. Cong,et al.  Microbiota regulation of inflammatory bowel disease and colorectal cancer. , 2013, Seminars in cancer biology.

[11]  Qiwen Ben,et al.  Body mass index increases risk for colorectal adenomas based on meta-analysis. , 2012, Gastroenterology.

[12]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[13]  Shuwen Liu,et al.  Autophagy contributes to modulating the cytotoxicities of Bcl-2 homology domain-3 mimetics. , 2013, Seminars in cancer biology.

[14]  R. Fitzgerald,et al.  A review of the current understanding and clinical utility of miRNAs in esophageal cancer. , 2013, Seminars in cancer biology.

[15]  Jun Yu,et al.  MicroRNA dysregulation in gastric cancer: a new player enters the game , 2010, Oncogene.

[16]  Jun Yu,et al.  Genome-wide association and sequencing studies on colorectal cancer. , 2013, Seminars in cancer biology.

[17]  M. R. Rubinstein,et al.  Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. , 2013, Cell host & microbe.

[18]  W. Leung,et al.  Increasing incidence of colorectal cancer in Asia: implications for screening. , 2005, The Lancet. Oncology.

[19]  S. Locarnini,et al.  Possible origins and evolution of the hepatitis B virus (HBV). , 2013, Seminars in cancer biology.

[20]  Ahmedin Jemal,et al.  International Trends in Liver Cancer Incidence Rates , 2011, Cancer Epidemiology, Biomarkers & Prevention.